GENVOR INC (GNVR:OTCMKTS)
$0.5 0 (0%)
Analysed GENVOR INC (GNVR:OTCMKTS) News Sources
Genvor Announces Strategic Memorandum of Understanding with Canlab International™ to Advance Commercial Peptide Pipeline
14-04-2026
yahoo.com
Genvor to Present at Centri Capital Conference on April 14
07-04-2026
yahoo.com
Genvor, Inc. Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026
05-03-2026
yahoo.com
Genvor Announces Strategic Expansion into Health and Wellness Market, Leveraging Proprietary AI-Accelerated BioCypher Platform to Develop Consumer Peptide Solutions
04-03-2026
yahoo.com
Genvor’s AGM182 Antifungal Peptide Technology Validated in Peer-Reviewed Publication in PhytoFrontiers™
11-02-2026
yahoo.com
Genvor Appoints Dr. George Stavrides as Executive Vice President, Business Development & Commercialization
28-01-2026
yahoo.com
Genvor, Inc. to Present at the 3rd Annual DealFlow Discovery Conference
20-01-2026
yahoo.com
Life Sciences Virtual Investor Forum Agenda Announced for December 11th
09-12-2025
yahoo.com
Genvor to Present at the Life Sciences Virtual Investor Forum December 11th
04-12-2025
yahoo.com
Genvor and Tuskegee University Announce Teaming Agreement to Advance Peptide Research and Sustainable Crop Protection Technologies
02-12-2025
yahoo.com
What is the current price of GENVOR INC (GNVR:OTCMKTS)?
The current price of GENVOR INC (GNVR:OTCMKTS) is $0.5.
GENVOR INC (GNVR:OTCMKTS) absolute price change since previous trading day?
The absolute price change of GENVOR INC (GNVR:OTCMKTS) since the previous trading day is $0.
GENVOR INC (GNVR:OTCMKTS) percentage price change since previous trading day?
The percentage price change of GENVOR INC (GNVR:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for GENVOR INC (GNVR:OTCMKTS)?
The most recent average sentiment score for GENVOR INC (GNVR:OTCMKTS) is 82 out of 100.
What is the most recent average sentiment for GENVOR INC (GNVR:OTCMKTS)?
The most recent sentiment for GENVOR INC (GNVR:OTCMKTS) is .
SEC-8K** Filing Available For GENVOR INC (GNVR:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.